IPO Approval for JD Capital-Invested Rongtai
CSRC recently announced that Shanghai Rongtai Health Technology Co., Ltd (Rongtai Health), one of JD Capital-invested companies, has been approved for its IPO and will soon go public on A-share market.
Rongtai Health, founded in 1997, is a health and longevity preservation product and service provider who focuses on massage apparatus. The company integrates research and development, production and sales and it has successfully applied for over 100 patents for utility models, designs and inventions. It is entitled as “Shanghai Famous Brand”, “Shanghai Science and Technology Little Giant”, “Shanghai Innovative Enterprise”, “High-tech Enterprise” and “Shanghai Enterprise Technology Center”, etc.
Rongtai Health has set up sale counters in most domestic high-end department stores, among which Yansha, New World, Yaohan, Golden Eagle and Friendship are long-term partners. The company has also diversified its market channel through cooperation with home appliance chain stores like Suning, Gome, service companies including high-end hotels, airports, clubs, automobile 4S stores, and online platforms like Taobao and JD.COM. Rongtai has built a global sales network covering countries and regions in Southeast Asia, Middle East, Europe and North America, and it is continuously expanding its sales market.
The Fund under JD Capital’s management became a shareholder of Rongtai Health in 2011, taking 13.44% shares before its IPO. From the beginning of 2016 till now, there have been eight JD Capital-invested companies succeeding in or getting prepared to get listed on A-share market, including Beiken Energy (002828), Fusenmei (002818), Xintai Natural Gas (603393), Dowell (300535), Monarch Sanitary Ware (002798), Haozhi Industrial (300503), Flag Chemical (approved) and Rongtai Health (approved).